Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine after Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: the NINJA Study Yasunori Murata , Shigeru Tanzawa , Toshihiro Misumi , Hiroshige Yoshioka , Eisaku Miyauchi , Kiichiro Ninomiya , Masafumi Takeshita , Kensaku Ito , Tatsuro Okamoto , Shunichi Sugawara , Yosuke Kawashima , Kazuki Hashimoto , Masahide Mori , Akihiko Miyanaga , Anna Hayashi , Hisashi Tanaka , Ryoichi Honda , Masafumi Nojiri , Yuki Sato , Akito Hata , Ken Masuda , Toshiyuki Kozuki , Takahisa Kawamura , Takuji Suzuki , Teppei Yamaguchi , Kazuhiro Asada , Satoshi Tetsumoto , Hiroshi Tanaka , Satoshi Watanabe , Yukihiro Umeda , Kakuhiro Yamaguchi , Shoichi Kuyama , Kosuke Tsuruno , Yuki Misumi , Hiroshi Kuraishi , Ken Yoshihara , Akira Nakao , Akihito Kubo , Toshihiko Yokoyama , Kana Watanabe , Nobuhiko Seki JTO clinical and research reports（2023）
关键词
Necitumumab, Immune checkpoint inhibitor, Platinum rechallenge, Skin disorder, Lung squamous cell carcinoma
AI 理解论文
溯源树
样例
